The Wfs1 gene codes for a protein with unknown function, but deficiency in this protein results in a range of neuropsychiatric and neuroendocrine syndromes. In the present study we aimed to find the functional networks influenced by Wfs1 in the hypothalamus. We performed gene expression profiling (Mouse Gene 1.0 ST Arrays) in Wfs1-deficient mice; 305 genes were differentially expressed with nominal P value Ͻ 0.01. FDR (false discovery rate)-adjusted P values were significant (0.007) only for two genes: C4b (tϭ9.66) and Wfs1 (t ϭ Ϫ9.03). However, several genes related to G protein signaling were very close to the FDR-adjusted significance level, such as Rgs4
gene expression profiling; Wfs1 gene; Wolfram syndrome; hypothalamus; Rgs4; C4b WOLFRAM SYNDROME (WS, MIM222300) is an autosomal recessive disorder most frequently characterized by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness (DID-MOAD), first described by Wolfram and Wagener (47) as a juvenile diabetes mellitus with optic atrophy (40) . Only insulin-dependent diabetes mellitus and progressive optic atrophy are necessary to confirm WS, and both of these syndromes may be present in childhood or adolescence (1) . WS can be characterized as polyendocrinopathy with significant pituitary deficiency and atrophy (10, 32) . In addition to these diagnostic syndromes, most WS patients have highly variable clinical symptoms including several neurological abnormalities such as nystagmus, mental retardation, and seizures (1) . Moreover, several studies have shown diffuse and widespread atrophy in the brain (33, 36) . Central respiratory failure due to brain stem atrophy has described as a common cause of death, indicating the significance of neurodegeneration in WS (1, 36) . In addition to the neurological manifestations, psychiatric illnesses have often been found in WS patients. The most prominent psychiatric manifestations in WS homozygous individuals are depression, violent or assaultive behavior, and organic brain syndromes (41) .
WS is caused by mutations in the Wfs1 gene, but the molecular function of the Wfs1 protein is not fully known. It is a transmembrane protein with 9 -11 segments and is located in the endoplasmic reticulum (ER) (14) . There is evidence that this protein plays a role in the regulation of ER Ca 2ϩ levels (31, 42) . Wfs1 is involved in the unfolded protein response, which is an adaptive response that counteracts ER stress (8) . ER stress is defined as an imbalance between the actual folding capacity of the ER and the demand (21) . Induction of ER stress with thapsigargin and tunicamycin causes significant upregulation of Wfs1 expression (8) . Wfs1 upregulatuion is caused by the downregulation of Smurf1 (12) . Smurf1 is an ER stressregulated E3 ligase that interacts with Wfs1 and promotes the ubiquitination and proteosomal degradation of Wfs1 (12) . Wfs1 therefore seems to act as a survival factor; it is upregulated when ER stress is present and its deficiency leads to more pronounced apoptosis (18) .
Wfs1 is involved in the activation and secretion of the bioactive peptides, including insulin. There is evidence that Wfs1 is related to the processing of vasopressin in the hypothalamus (9) . Previous studies indicated that Wfs1 knockout (KO) mice exhibit impaired glucose tolerance and are significantly smaller than their wild-type littermates despite elevated growth hormone and insulin-like growth factor-1 levels (20, 30) . These mice also eat less and exhibit lower motor activity compared with the wild-type (wt) animals. Moreover, these mice exhibit significant behavioral alterations, and they have impaired behavioral adaptation in stressful (novel) environment (25) .
Mutant mice lacking Wfs1 gene have been generated in three independent laboratories (18, 24, 34) . The aim of the present study was to analyze gene expression profiles in the hypothalamus of the most recent Wfs1 mutant mice, which were generated in our laboratory. The hypothalamus was chosen as this brain area plays a crucial role in the regulation of endocrine system, and the most prominent symptoms of WS seem to be related to endocrine deficiencies, with several studies suggesting that there are severe endocrine problems in WS patients and in mice with Wfs1 deficiency (9, 20, 30).
The aim of this study was to identify whether there are any altered functional networks in the hypothalamus of the Wfs1 KO mice at the level of gene expression, so as to understand the mechanisms underlying the altered endocrine system observed in WS.
MATERIALS AND METHODS

Animals and tissues.
Mice were housed under standard laboratory conditions on a 12 h light-dark cycle (lights on at 07:00) with free access to food and water. All animal experiments in this study were performed in accordance with the European Communities Directive (86/609/EEC) and permit (no. 39, October 7th, 2005) from the Estonian National Board of Animal Experiments.
We analyzed hypothalami from 10 Ϫ/Ϫ and 10 wt 129WfsKO (Wfs1 tm1Sira or Wfs1 tm1Koks ) mice. We used mice in the homogenous 129S6 genetic background with the aim of avoiding a confusing congenic footprint effect (20) . Mice were killed, brains removed, and the hypothalami dissected and snap-frozen in liquid nitrogen. Total RNA was extracted using the guanidine isothiocyanate method with TRIzol reagent (Invitrogen Life Technologies) (6) .
Gene expression profiling. Gene expression profiling was performed with Mouse Gene 1.0 ST arrays using the whole transcript sense target labeling kit (Affymetrix, Santa Clara, CA). Doublestranded cDNA was synthesized from 300 ng of total RNA according to standard Affymetrix protocols. Images were processed using the Affymetrix GeneChip Operating Software; the processed data (cel files) were further analyzed using Bioconductor software based on R programming language.
Quantitative real-time PCR. Quantitative real-time PCR (QRT-PCR)was performed using Taqman gene expression assays and Taqman RT-PCR chemistry to verify the differential expression of C4b and Rgs4 genes.
[ 35 S]GTP␥S autoradiography. For the basal [ 35 S]GTP␥S binding assay, the male mice (n ϭ 5-10 per group) were killed by decapitation; the brains were quickly removed, frozen in isopentane at Ϫ40°C, and stored at Ϫ80°C. We cut 14 m thick sections on a cryostat and thaw mounted them onto gelatin-coated slides. For the assay, the slides were brought up to room temperature and incubated for 15 min at room temperature in preincubation buffer (50 mM Tris·HCl, pH 7.5, 5 mM MgCl 2, 1 mM EDTA). Incubation was repeated once, and slides transferred into humidified chambers. Then, 500 l of incubation buffer (50 mM Tris·HCl pH 7.5, 5 mM MgCl2, 1 mM EDTA, 100 mM NaCl, 1 mM DTT, 0.1% BSA) containing 1 mM GDP was applied to each slide, and slides were incubated for 15 min at room temperature. The solution was discarded, and a mix of [ 35 S]GTP␥S (final concentration 0.04 nM) and 1 mM GDP in incubation buffer was applied, and slides were incubated for 60 min at 30°C. We stopped incubation by washing the slides for 2 min in ice-cold buffer (50 mM Tris·HCl, 100 mM NaCl); this step was repeated two more times and followed by a dip in ice-cold deionized water. Slides were dried under a stream of cold air and apposed against a sheet of medical photographic film for 48 h. Film was developed, images scanned, and densitometry analysis was performed using Scion Image for Windows program (National Institutes of Health, Bethesda, MD). GTP␥S binding was calculated as a percent of wt value in the ventral tegmental area (VTA).
Data analysis. The normalized, background subtracted, and modeled expression (robust microarray analysis) data were further analyzed using the limma package (Smyth, 2004; Smyth, 2005) and implemented in the statistical software R (http://www.r-project.org/) without further transformation (17) . There were 10 animals for each genotype, and a moderated t-test was used to detect significant mean differences between the KO and wt strains. False discovery rate (FDR) adjustment was used for multiple testing correction (39) . t-Test was also used for the analysis of real-time PCR data. Illustrations for this article were produced with R, GraphPad 5.0, and Ingenuity Pathway Analysis (IPA).
Functional annotation and network analysis. To define the functional networks of the differentially expressed genes, data were analyzed through the use of IPA (Ingenuity Systems, http://www. ingenuity.com). A data set containing Affymetrix probe set identifiers and corresponding fold change values was uploaded into the application. Each gene identifier was mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base to generate the list of focus genes. Networks of these focus genes were then algorithmically generated based on their connectivity. IPA calculates a significance score for each network. The score is generated using a P value calculation and is displayed as the negative logarithm of that P value. This score indicates the likelihood that the assembly of a set of focus genes in a network could be explained by random chance alone. A score of 2 indicates that there is a 1 in 100 chance that the focus genes are together in a network due to random chance.
Canonical pathways analysis identified the pathways from the IPA library of canonical pathways that were most significant to the data set. Molecules from the data set that were associated with a canonical pathway in the Ingenuity Knowledge Base were considered for the analysis. The significance of the association between the data set and the canonical pathway was measured in two ways: 1) A ratio of the number of molecules from the data set that map to the pathway divided by the total number of molecules that map to the canonical pathway is displayed, 2) Fisher's exact test was used to calculate a P value determining the probability that the association between the genes in the dataset and the canonical pathway is explained by chance alone.
Functional analysis was performed twice. First, we used the entire dataset, and in the second functional analysis, we analyzed a dataset containing only the top 1,000 genes with the lowest P values. This second analysis using a P value-filtered list was used to get a more focused and specific analysis.
RESULTS
Quality analysis and preprocessing. Quality control analysis indicated some technical problems with two chips, and these were removed from further analysis. Figure 1 illustrates the signal density in the remaining 18 chips.
Differential expression. Modified t-statistics revealed 305 genes to be differentially expressed with nominal P value Ͻ0.01. The list of top genes with the lowest P values was relatively heterogeneous, from complement component 4B and K-channel to transcriptional enhancer and G protein signal regulation (Rgs16 and Rgs4). Interestingly, the expression data were quite dispersed, and there wasn't very much overlap between genes with most extreme fold change values and with lowest P values. On the volcano plot (Fig. 2) , 100 genes with the most extreme fold change values are labeled as blue diamonds, and 100 genes with the lowest P values are labeled with red circles. According to the volcano plot, only four genes overlapped (blue diamonds with red circles). Differential expression of Wfs1 gene was statistically highly significant.
To address multiple testing we applied FDR. FDR-adjusted P values were significant (0.007) only for two genes: C4b (t ϭ 9.54) and Wfs1 (t ϭ Ϫ10.08). Basic statistical data are presented in the Table 1 . C4b was significantly overexpressed (log 2 fold change is 0.62) in the hypothalamus of the Wfs1 mutant mice.
To illustrate the differential gene expression pattern, we performed cluster analysis of the 100 genes with the lowest P values and generated a heat map (Fig. 3) . The genes with lowest P values clustered clearly by the genotype of animals. Interestingly, most of the genes in mutant mice were downregulated compared with the wt mice.
Functional analysis. IPA software was used for the functional annotation of the gene sets. The analysis including the entire data set revealed significant activation in the canonical pathway called "G protein-coupled receptor signaling" pathway (Table 2 , Fig. 4) . Namely, the gene expression of several genes related to G protein signaling was altered (Rgs16, Rgs4), and our dataset indicated quite a high enrichment ratio, 486/ 529. However, according to Fig. 4 , the changes of individual genes were not always unidirectional. For instance, based on fold changes, Syngap1 (synaptic RAS GTPase-activating protein 1) and Grk2 (G protein-coupled receptor kinase) had increased expression levels in KO mice. However, levels of Rgs16 (regulator of G protein signaling 16) and Rgs4 (regulator of G protein signaling 4) were decreased in KO mice. This is Summary of the results of differential gene expression analysis using limma package. logFC, log2 fold change; AveExpr, average expression; t value, value of moderated t-test; P value, P value; Adj. P value, false discovery rate (FDR)-corrected P value for multiple testing; B, B-statistics value: it is the log-odds that the gene is differentially expressed. HT, hypothalamus. possibly related to the different roles of the proteins in the different nodes in the canonical pathway: some are inhibitors and some are activators.
We also performed functional annotation of the top 1,000 genes with the lowest P values. With this filtering we expected to see more specific changes in the pattern of gene expression. We found that the gene expression profile in the hypothalami of the Wfs1 mutant mice had significant resemblance to the profiles of the following disease-related functions: psychological disorders (P ϭ 7.94E-06), bipolar disorder (P ϭ 1.71E- 04), mood disorder (P ϭ 2.06E-04), etc. (Table 3 ). Analysis of the molecular networks indicated similarity to the following networks (Table 4) : "hematological disease, immunological disease, gene expression" (score 38), "behavior, neurological disease, cell death" (score 36), etc. Functional analysis of canonical pathways indicated significant activation of the "acute phase response signaling" (P ϭ 1.6E-03, ratio 13/178) and "G␣12/13 signaling" (P ϭ 2.9E-03, ratio 10/128). Taken together, functional analysis of the gene expression profiles indicated changes in G protein signaling and in networks related to psychological and psychiatric diseases.
QRT-PCR validation of the microarray results. We wanted to verify the microarray findings using an independent gene expression method, and therefore, we performed QRT-PCR analysis of the C4b and Rgs4 genes. We found significant overexpression of C4b gene and significant downregulation of Rgs4 gene in the hypothalami of the Wfs1 KO mice (Fig. 5) .
GTP in vitro binding in brain slices. To verify functional changes related to the Rgs4 and G protein signaling, we performed in vitro GTP binding experiment on brain slices. We found significant decrease of the basal G protein binding the VTA region of Wfs1 mutant mice. Overview of the results of the analysis for the biological functions enriched in the list of differentially expressed genes. The disease-related biological functions disturbed in the HT of the Wfs1 mutant mice are shown.
DISCUSSION
The present study investigated the gene expression profile in the hypothalamus after deletion of the Wfs1 gene. Wfs1 gene deletion models the WS, a rare familiar disorder characterized by multiple endocrine failure (7, 47) . As in humans, the mice have very severe phenotype, which develops from the age of 20 wk (20, 30) . Previously, we described the growth failure and alterations in the growth hormone pathway in these mice (20) . Impaired glucose homeostasis and diabetic phenotype have been described in earlier studies by several groups (18, 34) . In addition, we have described reduced fertility in male Wfs1 KO mice (29) . As Wfs1 mutant mice have several endocrine disorders, functional analysis of the gene expression profile in the hypothalamus could identify the mechanisms mediating the endocrine dysfunction observed.
The main finding of our study was a statistically significant upregulation of the C4b (complement component 4B) gene in the hypothalamus. This gene is particularly interesting as it is mostly known for its role in the immune response as a factor in the classical activation pathway. However, several studies suggest C4b also also plays a role in brain pathologies, especially in the degenerative disorders (27) , as it has been implicated in Alzheimer's disease, autism, prion disease, and multiple sclerosis (4, 5, 19, 43, 44) . Neurodegeneration is one of the most important features of the WS (1, 35) . The complement system is involved in the early response, part of the innate immune response, and its role in neurobiology has been recognized (15) . Interestingly, functional analysis of the 1,000 most changed genes, revealed significant similarity with "acute phase response signaling" as a canonical pathway and "hematological disease, immunological disease, gene expression" as a molecular network. This finding indicates the potential role of innate immunity in the neurodegeneration caused by the mutation of Wfs1.
Interestingly, in our previous study of the gene expression profiles in the temporal lobe, we found significant downregulation of transthyretin (Ttr) in Wfs1 mutant mice (20) . Ttr has been implicated in amyloid-related degeneration: amyloid polyneuropathy, cardiac amyloidopathy, and amyloidosis in general (3, 38, 48) . As the Wfs1 mutation is related to the degeneration of several organs (islets, brain, heart, etc.), our previous and present findings suggest that molecular networks including C4b and Ttr could play a role in the neurodegeneration observed in Wfs1 mutant mice.
Other interesting genes that were altered in Wfs1 mice were Rgs16 (regulator of G protein signaling 16) and Rgs4 (regulator Overview of the results of the analysis of molecular networks found in the list of differentially expressed genes. Activated molecular networks in the HT of the Wfs1 mutant mice. are shown. Ϫ⌬CT transformed data Ϯ SE. *P Ͻ 0.05, ***P Ͻ 0.001, 2-sided t-test.
of G protein signaling 4). RGS proteins are a family of more than 30 proteins that act as GTPase-activating proteins (GAPs) for alpha subunits of heterotrimeric G proteins (2, 28) . RGS molecules drive G proteins into their inactive GDP-bound forms. This protein negatively regulates signaling upstream or at the level of the heterotrimeric G protein (28) . Rgs4 is widely expressed in the brain, while Rgs16 is predominantly expressed in the hypothalamus (11) . Rgs4 has been shown to be involved in the neuronal signal transmission and downregulation of G protein-coupled receptors in response to the chronic agonist stimulation (23, 46) . Rgs16 is involved in the regulation of circadian rhythms and in the regulation of islet survival and development of diabetes (13, 45) . Genetic variations in the Rgs4 gene are related to schizophrenia and mood disorders (16, 22, 37) . As WS patients suffer from psychiatric disorders and from diabetes, the RGS pathway seems to be a biologically relevant target, based on our findings. In addition, IPA suggested significant changes in the G protein-coupled receptor signaling pathway in the hypothalamus of the Wfs1 mutant mice (Fig. 2) . This finding of altered G protein signaling is supported by other studies. Significantly enhanced response to apomorphine was observed in the Wfs1 mutant mice, suggesting upregulation of postsynaptic dopaminergic receptors (25) . Increased sensitivity of postsynaptic receptors may develop from the decreased dopamine release (26) . Our study also confirmed significantly lower GTP binding in the midbrain of the Wfs1-deficient mice (Fig. 6) . These functional studies suggest the relevance of changes in RGS signaling in Wfs1 mutant mice.
In conclusion, Wfs1 deficiency induced changes in the C4b expression and G protein-coupled signaling in the hypothalamus of the Wfs1 mutant mice, and these molecular events could be involved in mediating some of the symptoms, such as neurodegeneration, seen in the Wfs1 mutant mice.
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